Articles Posted in ‘screening’

Sequencing techniques uncover mutations in genes that can increase cancer risk

Device on benchtop in lab, featuring open lid for placement of microarray chip and to the right, a read-out screen.

Sequencing the human genome was just the beginning—now that the findings from that landmark effort are widely available, scientists are working to put that data to work to understand the genetic causes of many diseases, including cancer, by using the latest sequencing techniques.

Microbes within our bodies may cause or contribute to cancer

Salmonella typhi_Credit CDC

The Human Microbiome Project (HMP) investigators will sequence, at minimum, 3,000 bacterial genomes that represent the human microbiome. To date, there are more than 1,000 bacterial genomes at various stages of sequencing.

Overview of the Prostate, Lung, Colorectal and Ovarian (PLCO) Cancer Screening Trial

In 1993, the National Cancer Institute launched one of the largest cancer screening trials ever planned in the United States, in an effort to answer the question of screening efficacy in four cancers: prostate, lung, colorectal, and ovarian. Ten centers across the country ultimately accrued more than 150,000 men and women for this study. Nineteen years after it began, PLCO has now released the trial’s final major outcome finding, for colorectal cancer.